Get started
Author

Rajan Yadav

Observed name: Dr Rajan Yadav
ORCID: 0000-0002-1551-8414
Observed ORCID: 0000-0002-1551-8414
OpenAlex ID: A5106973236
Objective and subjective assessment of xerostomia in patients of locally advanced head-and-neck cancers treated by intensity-modulated radiotherapy
2018 · Punita Lal, Vipul Nautiyal, et al. · Journal of Cancer Research and Therapeutics · 19
Extraosseous primary intracranial ewing sarcoma/peripheral primitive neuroectodermal tumor: Series of seven cases and review of literature
2018 · Amit Singh, Arun Srivastava, et al. · Asian Journal of Neurosurgery · 12
PDF
Long term results of comparison of concurrent low‑dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
2016 · Pramod Kumar Gupta, Punita Lal, et al. · South Asian Journal of Cancer · 11
PDF
Safety and Efficacy of Thalidomide and Hydroxyurea Combination in Beta Thalassemia Patients
2022 · Akanksha Garg, Kinnari Patel, et al. · Indian Journal of Hematology and Blood Transfusion · 8
Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
2020 · Shagun Misra, Rajan Yadav, et al. · Journal of Cancer Research and Therapeutics · 8
Haploidentical Stem Cell Transplantation: Half Match but More Hope!—Single Centre Experience from Western India
2023 · Akanksha Garg, Maharshi Trivedi, et al. · Indian Journal of Hematology and Blood Transfusion · 6
PDF
Evaluation of fatigue in head and neck cancer patients undergoing (intensity modulated radiation therapy) radiotherapy: A prospective study
2015 · Vipul Nautiyal, Punita Lal, et al. · Asian Journal of Oncology · 6
Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC)
2024 · Purvish M. Parikh, Amish Vora, et al. · South Asian Journal of Cancer · 5
PDF
Impact of Molecular and Cytogenetic Responses on Long-Term Outcomes in Children and Adolescents With Chronic Myeloid Leukemia: A Retrospective Study From India
2025 · Dipesh Dave, Maharshi Trivedi, et al. · Cureus · 3
PDF
Patient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigma
2024 · Satya Sadhan Sarangi, Rajan Yadav, et al. · International Journal of Molecular and Immuno Oncology · 3
A Retrospective Analysis of Pembrolizumab With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer: Experience From a Tertiary Care Hospital
2025 · Parag Roy, Rajan Yadav, et al. · Cureus · 2
PDF
Post Covid-19 Reactive Arthritis in Two Stem Cell Transplant Recipients
2022 · Sheshagiri Rao Ganta, Akanksha Garg, et al. · Indian Journal of Hematology and Blood Transfusion · 2
Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma
2021 · Jaikumar Patel, Akanksha Garg, et al. · Indian Journal of Hematology and Blood Transfusion · 2
Emerging role of immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
2025 · Goutham Sunny, Abinash Patnaik, et al. · International Journal of Molecular and Immuno Oncology · 1
The cost-effectiveness of chronic myeloid leukemia treatment strategies in the Indian healthcare context
2024 · Kushboo Ashwani Jain, Rajan Yadav · International Journal of Molecular and Immuno Oncology · 1
Neoadjuvant Chemotherapy for Borderline Resectable Head and Neck Cancers: A Comparative Study of Three-Drug and Two-Drug Regimens in a Low- and Middle-Income Country (LMIC) Context
2024 · Rajan Yadav, Harsha Panchal, et al. · Cureus · 1
PDF
Outcomes of Dose Escalation of Imatinib in Chronic Myeloid Leukemia Patients: A Retrospective Analysis From an Indian University Teaching Hospital
2024 · Rajan Yadav, Harsha Panchal, et al. · Cureus · 1
PDF
Addressing Challenges Faced by CML Patients and Physicians in SAARC Countries
2024 · Rajan Yadav · South Asian Journal of Cancer · 1
PDF
Real-World Effectiveness, Safety, and Tolerability of Adjuvant CDK4/6 Inhibitor Therapy
2026 · Kajal Shah, Harsha P Panchal, et al. · Cureus
PDF
Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care
2026 · Rajan Yadav, Masaoki Ito, et al. · Cancers
Real-world outcomes and immune-related adverse events with PD-1/ PD-L1 inhibitors in metastatic renal cell carcinoma: A prospective observational study
2026 · Satya Sadhan Sarangi, Ashutosh Jaiswal, et al. · Asian Journal of Oncology
PDF
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiotherapy for Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
2026 · Sonam Gupta, Satya Sarangi, et al. · Cureus
PDF
Outcomes of Patients With Appendiceal Neoplasms Based on Clinicopathological Features and Surgical Intervention: A Retrospective Observational Study at a Tertiary Cancer Centre in India
2026 · Nikhil Garg, Senthilkumar Moorthy, et al. · Cureus
Neoadjuvant pembrolizumab with paclitaxel and carboplatin in locally advanced esophageal and esophagogastric junction carcinoma: short-term outcomes of a single-center retrospective cohort
2026 · Yuganshu Gupta, Rajan Yadav, et al. · Indian Journal of Pharmaceutical and Biological Research
PDF
Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy
2026 · Goutham Sunny, Shrikanth Ravichandran, et al. · Journal of Kidney Cancer and VHL
PDF
Works count: 42
Citation count: 92
H-index: 6
I10-index: 3
Year
Topic
Type